Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 543-546, Vol. 69, No. 1
Mass Spectrometry Research
Center1 and Departments of Medicine and
Microbiology and Immunology,2 Vanderbilt
University School of Medicine, and Veterans Affairs Medical
Center,3 Nashville, Tennessee
Received 10 July 2000/Returned for modification 22 August
2000/Accepted 10 October 2000
The vacA gene of Helicobacter pylori strain
60190 encodes a 1,287-amino-acid protoxin, which undergoes cleavage of
a 33-amino-acid amino-terminal signal sequence and carboxy-terminal
proteolytic processing to yield a mature secreted toxin. Several
features of VacA suggest that it belongs to the autotransporter family of gram-negative bacterial secreted proteins. Based on matrix-assisted laser desorption ionization-time of flight mass spectrometric analysis, we calculate that the mature toxin has a mass of 88.2 ± 0.2 kDa and consists of approximately 821 amino acids.
Chronic colonization of the human
gastric mucosa by Helicobacter pylori is associated with
gastritis and an increased risk for development of peptic ulcer disease
and gastric malignancies (5). Most H. pylori
strains secrete a toxin (VacA) that induces multiple structural and
functional alterations in eukaryotic cells (see references
1 and 10 for reviews). H. pylori vacA encodes an ~139-kDa protoxin, which undergoes
cleavage of a 33-amino-acid amino-terminal signal sequence and
carboxy-terminal proteolytic processing to yield a mature secreted
toxin (2, 4, 14, 15) (see GenPept accession number
B53739). In various studies, the reported masses of mature secreted
VacA toxins have varied from 87 to 95 kDa, based on analysis by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (2, 4, 14,
15). Thus, the site (or sites) at which the VacA protoxin
undergoes carboxy-terminal proteolytic processing is not known. In this
study, we used matrix-assisted laser desorption ionization-time of
flight (MALDI-TOF) mass spectrometry to determine the precise molecular
mass of the secreted VacA toxin.
H. pylori strain 60190 (ATCC 49503) was cultured for 48 h at 37°C in sulfite-free brucella broth containing 0.5% charcoal. VacA was purified in an oligomeric form from the culture supernatant, as described previously (3). Purified VacA preparations
were analyzed by MALDI-TOF mass spectrometry, using a Voyager Elite (PerSeptive Biosystems, Framingham, Mass.) instrument equipped with a
pulsed nitrogen laser source operating at 337 nm. Mass spectra were
obtained in the delayed-extraction positive ion mode with an
accelerating voltage of 25 kV. Sinapinic acid (10 mg/ml in 70:30
[vol/vol] acetonitrile-0.1% trifluoroacetic acid) was used as a
matrix additive. The instrument was calibrated externally with bovine
serum albumin (MH+ = 66,431) for analysis of intact
VacA and was calibrated with bovine insulin (MH+ = 5,734.6) for analysis of VacA peptides. The molecular masses reported
in this paper are those of single-protonated species (MH+).
Based on MALDI-TOF analysis of purified VacA, we calculated the
molecular mass of VacA monomers to be 88.2 ± 0.2 kDa (value is
mean ± standard deviation, as are values given below) (Fig. 1). Purified VacA degrades during
prolonged storage into two fragments (of about 34 and 58 kDa,
respectively) which are derived from the amino terminus and the carboxy
terminus of the toxin, respectively (3, 15). Mass
spectrometric analysis of partially proteolysed VacA preparations
demonstrated two major peaks representing proteins with average
molecular masses of 33.4 ± 0.08 and 54.8 ± 0.1 kDa (Fig.
2). Thus, the experimentally determined
mass of intact VacA (88.2 kDa) corresponded closely to the sum of the
masses of two proteolytic fragments. The mass of the amino-terminal
fragment is consistent with proteolytic cleavage between amino acid 344 (alanine) and amino acid 345 (lysine) of the VacA protoxin (4, 15). The 54.8-kDa fragment sometimes could be resolved into a
series of clustered peaks with very similar molecular masses (Fig. 2),
which suggests the occurrence of proteolytic cleavage at multiple
sites. Clustered peaks were not readily detectable for the intact
88.2-kDa VacA protein (Fig. 1), but this may simply reflect limited
resolution with spectrometric analysis of this relatively large
protein.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.543-546.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Carboxy-Terminal Proteolytic Processing of
Helicobacter pylori Vacuolating Toxin
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (14K):
[in a new window]
FIG. 1.
MALDI-TOF mass spectrum of secreted, intact VacA from
H. pylori 60190 (MH+ = 88.2 ± 0.2 kDa). MH22+ denotes a peak corresponding to
doubly protonated VacA.

View larger version (12K):
[in a new window]
FIG. 2.
MALDI-TOF mass spectrum of spontaneously arising
proteolytic degradation products of VacA
(MaH+ = 33.4 ± 0.08 kDa and
MbH+ = 54.8 ± 0.1 kDa).
The spectrometric analyses shown in Fig. 1 and 2 were not sufficiently
precise to permit identification of the exact site of carboxy-terminal
VacA processing. Therefore, purified VacA was treated with cyanogen
bromide (CNBr) in 70% trifluoroacetic acid in water overnight at room
temperature, and the resulting peptides were dried and dissolved in a
0.1% trifluoroacetic acid aqueous solution prior to mass spectrometric
analysis. The molecular masses of six prominent peaks (1,692, 2,525, 4,331, 8,041, 10,618, and 11,220 Da) corresponded to predicted cyanogen
bromide products (amino acids 769 to 784, 137 to 160, 655 to 695, 697 to 768, 161 to 259, and 34 to 136 of the VacA protoxin, respectively)
(Fig. 3 and data not shown). Peaks
corresponding to three other predicted CNBr fragments (672, 1,274, and
40,783 Da) were not successfully detected. In addition, seven peaks of
similar size (ranging from 5,922 to 6,803 Da), all of which can be
derived only from a CNBr product that contains valine-792 at its amino
terminus (Fig. 3), were visualized. These peptides are predicted to
result from proteolytic cleavage after amino acid residues 846, 847, 848, 849, 850, 851, and 854 (4). Similar ragged ends were
not detected for any of the other CNBr-generated peptides (Fig. 3).
Notably, there are no methionine residues located in the region between
amino acids 846 and 855 (4), which indicates that these
peptides did not result solely from CNBr-mediated proteolytic cleavage. Therefore, we postulate that the family of seven similar-size peptides
are derived from the carboxy terminus of the secreted VacA toxin. The
predicted molecular mass of a VacA protein containing amino acids 34 to
854 of the protoxin is 88.3 kDa, a result that compares favorably with
the experimentally determined molecular mass of intact VacA, as
described above. The mature VacA toxin probably forms following a
proteolytic cleavage event between amino acids 854 and 855 (alanine and
leucine), and several individual amino acids are thereafter susceptible
to further nonspecific proteolysis. In agreement with this
interpretation, some preparations of CNBr-digested VacA exhibited a
single peak corresponding to amino acids 792 to 854, without associated
ragged ends (data not shown). Alternatively, the ragged ends may result
from nonspecific endoproteolysis at an exposed loop in the protoxin.
|
Proteins that are secreted into the extracellular space by
gram-negative bacteria must cross two different lipid bilayers of the
cell envelope. Four classes of secretory pathways (termed types I, II,
III, and IV, respectively) utilize accessory proteins in the export
process. In contrast, certain autotransporter proteins are secreted via
a pathway that does not require any accessory proteins (6, 7,
9). The prototype of the autotransporter protein family is
immunoglobulin A1 (IgA1) protease from Neisseria gonorrhoeae
(8, 11). Autotransporter proteins are typically comprised
of three functional domains, as follows: (i) an amino-terminal signal
sequence, (ii) a passenger domain (corresponding to the mature secreted
protein), and (iii) a carboxy-terminal domain that is rich in
amphipathic
-sheets (6, 7, 9). It is presumed that the
carboxy-terminal domain forms a
-barrel structure consisting of
antiparallel amphipathic
-sheets in the outer membrane and that this
structure mediates translocation of the secreted passenger domain from
the periplasm to the bacterial cell surface (6-9).
Based on various features of the vacA gene structure,
H. pylori VacA has been classified in the autotransporter
family of secreted proteins (4, 6, 7, 9, 14). Secondary
structure predictions suggest that a 35-kDa portion of the VacA
carboxy-terminal domain is rich in amphipathic
-sheets, and this
region exhibits low-level homology to members of the family of
autotransporter proteins (6, 9, 17). In addition, at the
carboxy terminus of VacA there is a phenylalanine-containing motif that
is commonly found in autotransporter proteins, as well as in numerous
gram-negative bacterial outer membrane proteins (4, 7).
Isogenic H. pylori mutant strains in which the
carboxy-terminal VacA domain is disrupted fail to express or secrete
any detectable VacA, which is probably attributable to the degradation
of export-incompetent toxin precursors within the periplasm
(14).
The molecular mass of the carboxy-terminal VacA domain that remains associated with bacterial cells is reported to be 33 kDa (15). Interestingly, the combined masses of known VacA domains (i.e., the N-terminal signal sequence [3 kDa], the secreted toxin [88.2 kDa], and the carboxy terminal domain [33 kDa]) is only 124 kDa, which is considerably less than the predicted mass of the VacA protoxin (139 kDa). We speculate that the VacA protoxin may undergo proteolytic cleavage at multiple sites downstream from amino acid 854 of the protoxin, which would yield the previously identified 33-kDa cell-associated domain (15), as well as a fragment of ~15 kDa. Similar carboxy-terminal proteolytic processing at multiple sites has been described for N. gonorrhoeae IgA1 protease (8, 11).
Following translocation of the passenger domain through the outer
membrane, several autotransporter proteins, including N. gonorrhoeae IgA1 protease, undergo autoproteolytic cleavage, which results in release of the secreted protein from the cell-associated carboxy-terminal
-barrel domain (6). Thus, there has
been speculation that VacA might possess similar autoproteolytic
activity. In accordance with this hypothesis, the cytotoxic activity of VacA can be blocked by treatment of VacA with 3,4-dichloro-isocoumarin (a serine protease inhibitor), and some features of the amino-terminal portion of VacA are related to serine proteases (13).
However, at present there is no direct experimental evidence that VacA possesses proteolytic activity (10, 13). Moreover,
H. pylori mutant strains, constructed with in-frame deletion
mutations in the portion of vacA that encodes the
amino-terminal portion of the toxin, express and secrete truncated
vacA products that undergo carboxy-terminal proteolytic
processing (12, 16). This indicates that an intact
amino-terminal portion of VacA is not required for proteolytic
processing of the protoxin. At present, we favor the hypothesis that
carboxy-terminal proteolytic processing of VacA is mediated by an
independent membrane-associated protease, rather than occurring as an
autoproteolytic event. Potentially, the identification of the site of
carboxy-terminal VacA processing will permit future studies in which
the relevant H. pylori protease can be identified.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by the National Institutes of Health (R01 AI-39657 and DK-53623) and the Department of Veterans Affairs.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, A3310 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232. Phone: (615) 322-2035. Fax: (615) 343-6160. E-mail: covertl{at}ctrvax.vanderbilt.edu.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cover, T. L. 1996. The vacuolating cytotoxin of Helicobacter pylori. Mol. Microbiol. 20:241-246[CrossRef][Medline]. |
| 2. |
Cover, T. L., and M. J. Blaser.
1992.
Purification and characterization of the vacuolating toxin from Helicobacter pylori.
J. Biol. Chem.
267:10570-10575 |
| 3. |
Cover, T. L.,
P. I. Hanson, and J. E. Heuser.
1997.
Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly.
J. Cell Biol.
138:759-769 |
| 4. |
Cover, T. L.,
M. K. R. Tummuru,
P. Cao,
S. A. Thompson, and M. J. Blaser.
1994.
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.
J. Biol. Chem.
269:10566-10573 |
| 5. | Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741[Abstract]. |
| 6. | Henderson, I. R., F. Navarro-Garcia, and J. P. Nataro. 1998. The great escape: structure and function of the autotransporter proteins. Trends Microbiol. 6:370-378[CrossRef][Medline]. |
| 7. | Jose, J., F. Jahnig, and T. F. Meyer. 1995. Common structural features of IgA1 protease-like outer membrane protein autotransporters. Mol. Microbiol. 18:378-380[CrossRef][Medline]. |
| 8. | Klauser, T., J. Pohlner, and T. F. Meyer. 1993. The secretion pathway of IgA protease-type proteins in Gram-negative bacteria. Bioessays 15:799-805[CrossRef][Medline]. |
| 9. | Loveless, B. J., and M. H. Saier. 1997. A novel family of channel-forming, autotransporting, bacterial virulence factors. Mol. Membrane Biol. 14:113-123[Medline]. |
| 10. | Montecucco, C., E. Papini, M. de Bernard, J. L. Telford, and R. Rappuoli. 1999. Helicobacter pylori vacuolating cytotoxin and associated pathogenic factors, p. 264-283. In J. E. Alouf, and J. H. Freer (ed.), The comprehensive sourcebook of bacterial protein toxins. Academic Press, San Diego, Calif. |
| 11. | Pohlner, J., R. Halter, K. Beyreuther, and T. F. Meyer. 1987. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 325:458-462[CrossRef][Medline]. |
| 12. | Reyrat, J.-M., S. Lanzavecchia, P. Lupetti, M. de Bernard, C. Pagliaccia, V. Pelicic, M. Charrel, C. Ulivieri, N. Norais, X. Ji, V. Cabiaux, E. Papini, R. Rappuoli, and J. L. Telford. 1999. 3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J. Mol. Biol. 290:459-470[CrossRef][Medline]. |
| 13. | Rossetto, O., M. de Bernard, R. Pellizzari, G. Vitale, P. Caccin, G. Schiavo, and C. Montecucco. 2000. Bacterial toxins with intracellular protease activity. Clin. Chim. Acta 291:189-199[CrossRef][Medline]. |
| 14. | Schmitt, W., and R. Haas. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12:307-319[Medline]. |
| 15. |
Telford, J. L.,
P. Ghiara,
M. Dell'Orco,
M. Comanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci,
Z. Xiang,
E. Papini,
C. Montecucco,
L. Parente, and R. Rappuoli.
1994.
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658 |
| 16. |
Vinion, A. D.,
M. S. McCLain,
D. M. Czajkowsky,
H. Iwamoto,
D. Ye,
P. Cao,
W. Schraw,
G. Szabo,
S. R. Blanke,
Z. Shao, and T. L. Cover.
1999.
A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.
J. Biol. Chem.
274:37736-37742 |
| 17. | Wang, H.-J., P. C. L. Chang, C.-H. Kuo, C.-S. Tzeng, and W.-C. Wang. 1998. Characterization of the C-terminal domain of Helicobacter pylori vacuolating toxin and its relationship with extracellular toxin production. Biochem. Biophys. Res. Commun. 250:397-402[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»